2,851
edits
Nicotinamide Mononucleotide (NMN): Difference between revisions
Nicotinamide Mononucleotide (NMN) (view source)
Revision as of 20:44, 2 December 2023
, 2 December 2023→Potential Benefits
No edit summary |
|||
| Line 143: | Line 143: | ||
* '''Diabetes''': increased muscle insulin sensitivity, insulin signaling, and remodeling in prediabetic women{{pmid|33888596}} | * '''Diabetes''': increased muscle insulin sensitivity, insulin signaling, and remodeling in prediabetic women{{pmid|33888596}} | ||
* '''Telomere''': increased telomere length{{pmid|34912838}} | * '''Telomere''': increased telomere length{{pmid|34912838}} | ||
* Hypertension: {{pmid|37718359}} | * '''Hypertension''': significantly lowers blood pressure in mild hypertension adults{{pmid|37718359}} | ||
|} | |} | ||